Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-576,400
Closed -$43.6M 4235
2021
Q3
$43.6M Sell
576,400
-579,800
-50% -$44.9M 0.02% 577
2021
Q2
$89.4M Buy
1,156,200
+528,800
+84% +$40.8M 0.04% 323
2021
Q1
$44M Buy
+627,400
New +$47.4M 0.02% 502
2015
Q1
Sell
-3,900
Closed -$179K 7108
2014
Q4
$179K Sell
3,900
-7,200
-65% -$337K ﹤0.01% 4739
2014
Q3
$501K Sell
11,100
-12,300
-53% -$576K ﹤0.01% 3952
2014
Q2
$1.08M Buy
23,400
+7,000
+43% +$330K ﹤0.01% 3261
2014
Q1
$754K Buy
16,400
+16,000
+4,000% +$700K ﹤0.01% 3544
2013
Q4
$16K Sell
400
-33,000
-99% -$1.3M ﹤0.01% 6816
2013
Q3
$1.2M Buy
33,400
+15,300
+85% +$578K ﹤0.01% 3147
2013
Q2
$671K Buy
+18,100
New +$646K ﹤0.01% 3873

Other funds holding DOX

Barclays's DOX Position: Q1 2026 in Review

Barclays reduced its Amdocs (DOX) stake by 33% in Q1 2026, selling an estimated $5.85M and leaving 164,130 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Barclays first reported a position in DOX in Q2 2013 and has held it in 51 quarters since. The position peaked at $30.2M in Q1 2024. 474 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Barclays held 164,130 shares of Amdocs worth $10.7M as of Q1 2026.
  • Barclays sold 79,987 Amdocs shares in Q1 2026, an estimated $5.85M.
  • Amdocs made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1416 holding.
  • Barclays first reported a position in Amdocs in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Amdocs position peaked at $30.2M in Q1 2024.
  • 474 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.